Select Medical Holdings Corporation reported revenue of $1,363.4 million for the third quarter ended September 30, 2025, an increase of 7.2% compared to $1,271.6 million in the same quarter of the previous year. Income from continuing operations before other income and expense rose 32.9% to $73.0 million, up from $54.9 million in the prior year period. Income from continuing operations, net of tax, increased 7.0% to $44.2 million, compared to $41.3 million for the same quarter in 2024. For the nine months ended September 30, 2025, revenue was $4,056.2 million, representing a 4.7% increase over $3,874.5 million in the prior year period. The company reaffirmed its 2025 full-year outlook for revenue in the range of $5.3 billion to $5.5 billion and Adjusted EBITDA between $510.0 million and $530.0 million. The outlook for fully diluted earnings per share was increased to a range of $1.14 to $1.24. Net income attributable to Select Medical's common stockholders for the third quarter was $55.6 million, compared to $28.8 million for the same period last year. Total earnings per common share were $0.43, up from $0.23 in the prior year quarter.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Select Medical Holdings Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: PH11409) on October 30, 2025, and is solely responsible for the information contained therein.
Comments